Jeffrey Ubben

Latest Articles

2017-07-alpha-stephen-taub-value-act-valeant-pharmaceuticals-small.jpg

Jeffrey Ubben’s ValueAct Continues to Surge Despite its Valeant Stake

Stephen Taub July 14, 2017

The Morning Brief: Corporate Execs, ValueAct’s Ubben Unveil Governance Principles

Amanda Cantrell, Kaitlin Ugolik July 22, 2016

ValueAct’s Valeant Problem

July 21, 2016

The Morning Brief: Valeant Surges, but Big Problems Remain

Stephen Taub March 22, 2016

Keeping Tabs on the Damage from a Cratering Valeant

Stephen Taub March 21, 2016

Valeant’s Winners and Losers

Stephen Taub March 16, 2016

ValueAct Grows Its Cash Pile, but Not for Dry Powder

Stephen Taub March 7, 2016

ValueAct Is Seeking Longer-Term Capital

Stephen Taub November 24, 2015

ValueAct, TCI Faring Better than Most Activists

Stephen Taub October 9, 2015

The Morning Brief: ValueAct’s Ubben to Join 21st Century Fox Board

Stephen Taub September 30, 2015

Good Guys: Jeffrey Ubben And the Value of Crowds

Danielle Beurteaux September 22, 2015

The Morning Brief: Valiant Capital Scrambles Toward Break-even

Stephen Taub June 18, 2015

ValueAct Takes Stake in Twenty-First Century Voting Shares

Stephen Taub May 19, 2015

Activists Turn Out a Strong First Quarter

Stephen Taub April 21, 2015

Boston Partner Todd Bourell to Leave ValueAct Capital

Stephen Taub November 14, 2014

Despite Difficult Market, Activists Continue to Perform

Stephen Taub April 15, 2014

Jeffrey Ubben’s ValueAct Scores in Good Year for Activists

Stephen Taub January 7, 2014

ValueAct Takes a Nonactivist Stake in Allison—for Now

Stephen Taub November 14, 2013

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
12/F, The Spaces
8 Queen's Road East
Wanchai, Hong Kong
P: +852 2912 8001

Corporate

About Us

Management

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Custom Research

Reprints

FAQs

Events

Events Calendar

Memberships

Market Intelligence

Data & Analysis

Guest Contributors

Insights

Research

Sponsored

Strategic Partners

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.02.01 build:2025-05-20 Login